You can reach the authorized official at the following phone number 90.
The authorized official title (position) is ADMINISTRATIVE SUPERVISOR. The authorized official registered with the 1013591494 NPI Number is REBECCA STUCKEY. The contact numbers associated with the mailing address are: The provider's official mailing address is: įLORIDA RETINA INSTITUTE JAMES A STAMAN MD LLC can be reached at the following phone number(s): NPI Number information was last time updated on. The enumeration date of this NPI Number is. Name (which is a provider name or healthcare organization name) - FLORIDA RETINA INSTITUTE JAMES A STAMAN MD LLC. Matthew Cunningham, FASRS, serves as an examiner for the American Board of Ophthalmology.ĭoctor Cunningham joined Florida Retina Institute in 2013.NPI Number 1013591494 has the "Organization" type of ownership and has been registered to the following primary business legal Cunningham completed a fellowship in vitreoretinal surgery and diseases at the University of Iowa Hospitals and Clinics. He completed an internship and ophthalmology residency at Baylor College of Medicine. Cunningham receives Fellow of the American Society of Retina Specialists (FASRS) designationĭoctor Cunningham holds a Bachelors of Science degree from the University of Florida and earned his medical degree, Cum Laude with Honors in Research, from the University of Florida College of Medicine. Please click for more detailed information NEWS! Dr. Cunningham, MD, FASRS, congratulations on your new Fellow of the ASRS designation and this outstanding achievement!
#FLORIDA RETINA INSTITUTE DAYTONA BEACH PROFESSIONAL#
Matthew Cunningham has qualified to receive the new Fellow of The American Society of Retina Specialists (FASRS) designation! The FASRS is awarded based on criteria that recognize members in good standing who have demonstrated consistent commitment to the Society, ASRS, expertise in the management of vitreoretinal disorders, and the highest ethical and professional standards. He currently serves as the Research Director at Florida Retina Institute, and is the Principal Investigator for multiple clinical trials including: Diabetic Retinopathy Clinical Research Network (DRCR) Protocol W, Protocol AC, and Protocol AD Clearside TOPAZ Study Allergan Phase 3 Abicipar Pegol Chengdu Study for Neovascular Age-Related Macular Degeneration.ĭr.
Cunningham has a particular interest in clinical trials. During residency, he performed multiple research projects in the Ocular Surface Center at Baylor College of Medicine.ĭr. In medical school, he spent time at the National Eye Institute’s Laboratory of Ocular Immunology. Cunningham has extensive experience with research during his career. Junior Alpha Omega Alpha National Medical Honor Society,ĭr. Goodman Trust Award, Research Day Presentation Hospitals and Clinics Cullen Eye Institute Goar Award forĢnd Place, Baylor College of Medicine Lions Eye Bankįoundation Milton Boniuk Resident Research Awardĭeanne Barlow Romrell Professionalism in Medicine MemorialĪward, University of Florida College of Medicine
Hospitals and Clinics Ophthalmology Fellow Teaching Award, Leinfelder Award for the Best Fellow Research Project, May Rinehart Surgery Center, Orlando Health Lake Mary Honors and AwardsĬertificate of Appreciation, The American Board of Ophthalmology, 2019 - 2022 Orlando Health Orlando Regional Medical Center Iowa Hospitals and Clinics, Iowa City, IA Certificationĭiplomate, American Board of Ophthalmologyĭiplomate, National Board of Medical Examiners Assocations and Affiliations Residency, Ophthalmology, Baylor College of Medicine, Cullenįellowship, Vitreoretinal Surgery and Diseases, University of Internship, Internal Medicine, Baylor College of Medicine, Bachelor of Science (B.S.), Interdisciplinary Studies in Basicīiomedical Sciences Cum Laude, University of Florida, Gainesville, FLĭoctor of Medicine (M.D.), Cum Laude with Honors in Research, University of Florida College of Medicine,
0 kommentar(er)
